OTC · CIK 0001621227
ADAPY Adaptimmune Therapeutics PLC
Insider trading from SEC Form 4. Last filing Sep 3, 2025. Close $0.03 on Oct 9, 2026, +2900% from the 52-week low and -86% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
ADAPYOct 9, 2026 · close 0.03
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Adaptimmune Therapeutics PLC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Gavin Wood Chief Financial Officer sell | $950 96,000 shares | -100% | - | |
| 40Moderate | William C Bertrand JR Chief Operating Officer sell | $2,091 207,000 shares | -17% | - | |
| 56Moderate | Ali Behbahani director sell | $229k 19,500,000 shares | -100% | - | |
| 47Moderate | EcoR1 Capital, LLC owner sell | $6.9M 64,052,538 shares | -39% | - | |
| 50Moderate | Adrian Rawcliffe Chief Executive Officer sell | $18k 30,601 shares | -41% | - | |
| 45Moderate | William C Bertrand JR Chief Operating Officer sell | $3,243 5,584 shares | -43% | - | |
| 40Moderate | John Lunger Chief Patient Supply Officer sell | $3,243 5,584 shares | -43% | - | |
| 40Moderate | Elliot Norry Chief Medical Officer sell | $3,243 5,584 shares | -43% | - | |
| 55Moderate | William C Bertrand JR Chief Operating Officer sell | $11k 19,542 shares | -193% | - | |
| 50Moderate | John Lunger Chief Patient Supply Officer sell | $11k 19,542 shares | -193% | - | |
| 50Moderate | Elliot Norry Chief Medical Officer sell | $13k 22,195 shares | -219% | - | |
| 40Moderate | Cintia Piccina Chief Commercial Officer sell | $7,467 12,991 shares | -41% | - | |
| 66Notable | Adrian Rawcliffe Chief Executive Officer sell | $35k 59,569 shares | -196% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 2, 2025 | Gavin Wood Chief Financial Officer | 16,000 0.01% of outstanding | $942 | Sep 2, 2025 | none |
| Aug 29, 2025 | William Bertrand Chief Operating Officer | 34,500 0.01% of outstanding | $2,070 | Aug 28, 2025 | none |
| Aug 15, 2025 | New Enterprise Associates, 16 LP Affiliate | 3,250,000 0.20% of outstanding | $231k | Aug 15, 2025 | none |
| Aug 15, 2025 | New Enterprise Associates, 14 LP Affiliate | 13,829,778 0.87% of outstanding | $982k | Aug 15, 2025 | none |
| Jan 17, 2025 | Rawcliffe Adrian Chief Executive Officer | 30,601 0.01% of outstanding | $18k | Jan 17, 2025 | $35k |
| Jan 17, 2025 | Bertrand William C JR Chief Operating Officer | 5,584 0.00% of outstanding | $3,243 | Jan 17, 2025 | $11k |
| Jan 17, 2025 | Lunger John Chief Patient Supply Officer | 5,584 0.00% of outstanding | $3,243 | Jan 17, 2025 | $11k |
| Jan 17, 2025 | Norry Elliot Chief Medical Officer | 5,584 0.00% of outstanding | $3,243 | Jan 17, 2025 | $13k |
| Jan 15, 2025 | Rawcliffe Adrian Chief Executive Officer | 30,473 0.01% of outstanding | $18k | Jan 13, 2025 | none |
| Jan 15, 2025 | Lunger John Chief Patient Supply Officer | 9,739 0.00% of outstanding | $5,726 | Jan 13, 2025 | none |
| Jan 15, 2025 | Norry Elliot Chief Medical Officer | 12,392 0.00% of outstanding | $7,286 | Jan 13, 2025 | none |
| Jan 15, 2025 | Piccina Cintia Chief Commercial Officer | 12,991 0.01% of outstanding | $7,467 | Jan 15, 2025 | none |
| Jan 15, 2025 | Bertrand William C JR Chief Operating Officer | 9,739 0.00% of outstanding | $5,726 | Jan 13, 2025 | none |
Transactions
The last 36 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Gavin Wood Chief Financial Officer | SOpen-market sale Ordinary Shares with a nominal value of GBP0.001 per share | -96,000 | $0.01 | $950 | 0 | Sep 3, 2025 |
| Aug 28, 2025 | William C Bertrand JR Chief Operating Officer | SOpen-market sale Ordinary Shares with a nominal value of GBP0.001 per share | -207,000 | $0.01 | $2,091 | 986,352 | Aug 29, 2025 |
| Aug 15, 2025 | Ali Behbahani director | SOpen-market sale Ordinary Shares with a nominal value of 0.001 GBP per shareindirect: See Note 3 | -4,828,206 | $0.01 | $53k | 14,671,794 | Aug 19, 2025 |
| Aug 18, 2025 | Ali Behbahani director | SOpen-market sale Ordinary Shares with a nominal value of 0.001 GBP per shareindirect: See Note 3 | -14,671,794 | $0.01 | $176k | 0 | Aug 19, 2025 |
| Jul 28, 2025 | EcoR1 Capital, LLC owner | SOpen-market sale Ordinary Sharesindirect: See Note | -33,931,740 | $0.11 | $3.8M | 130,492,680 | Jul 30, 2025 |
| Jul 29, 2025 | EcoR1 Capital, LLC owner | SOpen-market sale Ordinary Sharesindirect: See Note | -2,687,460 | $0.10 | $272k | 127,805,220 | Jul 30, 2025 |
| Jul 30, 2025 | EcoR1 Capital, LLC owner | SOpen-market sale Ordinary Sharesindirect: See Note | -27,433,338 | $0.10 | $2.8M | 100,371,882 | Jul 30, 2025 |
| Feb 20, 2025 | Adrian Rawcliffe Chief Executive Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +5,143,248 | $0.00 | $0 | 5,143,248 | Feb 20, 2025 |
| Feb 20, 2025 | Elliot Norry Chief Medical Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,612,032 | $0.00 | $0 | 1,612,032 | Feb 20, 2025 |
| Feb 20, 2025 | William C Bertrand JR Chief Operating Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,612,032 | $0.00 | $0 | 1,612,032 | Feb 20, 2025 |
| Feb 20, 2025 | Cintia Piccina Chief Commercial Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,612,032 | $0.00 | $0 | 1,612,032 | Feb 20, 2025 |
| Feb 20, 2025 | John Lunger Chief Patient Supply Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,612,032 | $0.00 | $0 | 1,612,032 | Feb 20, 2025 |
| Feb 20, 2025 | Joanna Elizabeth Brewer Chief Scientific Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,612,032 | $0.00 | $0 | 1,612,032 | Feb 20, 2025 |
| Feb 20, 2025 | William C Bertrand JR Chief Operating Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,074,696 | $0.00 | $0 | 1,074,696 | Feb 20, 2025 |
| Feb 20, 2025 | Joanna Elizabeth Brewer Chief Scientific Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,074,696 | $0.00 | $0 | 1,074,696 | Feb 20, 2025 |
| Feb 20, 2025 | Cintia Piccina Chief Commercial Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,074,696 | $0.00 | $0 | 1,074,696 | Feb 20, 2025 |
| Feb 20, 2025 | Elliot Norry Chief Medical Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,074,696 | $0.00 | $0 | 1,074,696 | Feb 20, 2025 |
| Feb 20, 2025 | Adrian Rawcliffe Chief Executive Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +3,428,832 | $0.00 | $0 | 3,428,832 | Feb 20, 2025 |
| Feb 20, 2025 | John Lunger Chief Patient Supply Officer | AGrant or award Option to purchase Ordinary Sharesderivative | +1,074,696 | $0.00 | $0 | 1,074,696 | Feb 20, 2025 |
| Jan 17, 2025 | Adrian Rawcliffe Chief Executive Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -30,601 | $0.58 | $18k | 44,327 | Jan 17, 2025 |
| Jan 17, 2025 | William C Bertrand JR Chief Operating Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -5,584 | $0.58 | $3,243 | 7,510 | Jan 17, 2025 |
| Jan 17, 2025 | John Lunger Chief Patient Supply Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -5,584 | $0.58 | $3,243 | 7,510 | Jan 17, 2025 |
| Jan 17, 2025 | Elliot Norry Chief Medical Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -5,584 | $0.58 | $3,243 | 7,510 | Jan 17, 2025 |
| Jan 13, 2025 | Adrian Rawcliffe Chief Executive Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -12,539 | $0.59 | $7,372 | 17,801 | Jan 15, 2025 |
| Jan 15, 2025 | Cintia Piccina Chief Commercial Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -12,991 | $0.57 | $7,467 | 18,421 | Jan 15, 2025 |
| Jan 13, 2025 | Elliot Norry Chief Medical Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -4,268 | $0.59 | $2,509 | 5,845 | Jan 15, 2025 |
| Jan 13, 2025 | William C Bertrand JR Chief Operating Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -4,268 | $0.59 | $2,509 | 5,845 | Jan 15, 2025 |
| Jan 13, 2025 | John Lunger Chief Patient Supply Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -4,268 | $0.59 | $2,509 | 5,845 | Jan 15, 2025 |
| Jan 13, 2025 | Adrian Rawcliffe Chief Executive Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -17,934 | $0.59 | $11k | 25,711 | Jan 15, 2025 |
| Jan 13, 2025 | Elliot Norry Chief Medical Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -8,124 | $0.59 | $4,776 | 11,516 | Jan 15, 2025 |
| Jan 13, 2025 | John Lunger Chief Patient Supply Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -5,471 | $0.59 | $3,216 | 7,623 | Jan 15, 2025 |
| Jan 13, 2025 | William C Bertrand JR Chief Operating Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -5,471 | $0.59 | $3,216 | 7,623 | Jan 15, 2025 |
| Jan 15, 2025 | Adrian Rawcliffe Chief Executive Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -29,096 | $0.57 | $17k | 41,582 | Jan 15, 2025 |
| Jan 15, 2025 | Elliot Norry Chief Medical Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -9,803 | $0.57 | $5,635 | 13,756 | Jan 15, 2025 |
| Jan 15, 2025 | John Lunger Chief Patient Supply Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -9,803 | $0.57 | $5,635 | 13,756 | Jan 15, 2025 |
| Jan 15, 2025 | William C Bertrand JR Chief Operating Officer | SOpen-market sale American Depositary Shares representing Ordinary Shares | -9,803 | $0.57 | $5,635 | 13,756 | Jan 15, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Ali Behbahaniowner, director
- William C Bertrand JRChief Operating Officer
- Joanna Elizabeth BrewerChief Scientific Officer
- EcoR1 Capital, LLCowner, director
- John LungerChief Patient Supply Officer
- Elliot NorryChief Medical Officer
- Cintia PiccinaChief Commercial Officer
- Adrian RawcliffeChief Executive Officer
- Gavin WoodChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.